Detalhe da pesquisa
1.
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Lancet;
399(10324): 521-529, 2022 02 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35074136
2.
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-51617
3.
Randomized immunogenicity and safety study of heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine
Não convencional
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-51175